Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody

BACKGROUND: Donor-specific antibodies (DSA) to human leukocyte antigen increase the risk of accelerated rejection and allograft damage and reduce the likelihood of successful transplantation. Patients with full-thickness facial burns may benefit from facial allotransplantation. However, they are at...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelb, Bruce E., Diaz-Siso, J. Rodrigo, Plana, Natalie M., Jacoby, Adam, Rifkin, William J., Khouri, Kimberly S., Ceradini, Daniel J., Rodriguez, Eduardo D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985128/
https://www.ncbi.nlm.nih.gov/pubmed/29888023
http://dx.doi.org/10.1155/2018/7691072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985128/
https://www.ncbi.nlm.nih.gov/pubmed/29888023
http://dx.doi.org/10.1155/2018/7691072

Ejemplares similares